
“Looking for the very highest quality products and the consistency of a high-tech pharmaceuticals operation? Vida expects to file its licensing application before the end of April, a schedule that should allow it to have the necessary license in hand by the third quarter of this year. In the meantime, the company is raising $1.5 million at $.25 per share. That represents a market value of only $6 million for a company that now owns a 315,000-square-foot production plant with a replacement value estimated at $30 million. Personally, I think this will turn out to be an extraordinary investment. In less than a year’s time, this $.25 financing round is going to look extremely cheap.”
Related posts:
Introducing Europe’s Frightening New Tax Directive
Need a New Knee? This Lithuanian Clinic Will Give You One for Bitcoin
Prison State Chronicles
In New York, Annoying Someone Is No Longer A Felony
Crisis Investing in Cyprus
US Supreme Court Rejects Marijuana Reclassification Appeal
OKC Bombing: Secret Police Murder and Cover-Up
Illinois Ranked Last In Personal Freedoms, New Hampshire #4
DOE Green Energy Loans: $11.45 million per job and a rounding error’s worth of averted carbon emissi...
Greenwald: Use of NSA metadata to find drone targets kills civilians
Why is California Jailing Landscapers? Don't Cops Have Better Things to Do?!
Bolton Opposed To Both Syria Resolution And Obama Seeking Congress Approval
Bitcoin: Getting Down to Virtual Currency Basics
The Snowden case: U.S. data and security industries weakened
Toppling Syria planned years ago